Silo Pharma, Inc.

Healthcare · Biotechnology · United States

Last price 1.25 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.99M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a ...